These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19947232)

  • 1. [Natriuretic peptides, renal impairment and onset of cardiovascular complications].
    Pudil R; Tichý M
    Vnitr Lek; 2009 Oct; 55(10):913-4. PubMed ID: 19947232
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure.
    Mark PB; Petrie CJ; Jardine AG
    Semin Dial; 2007; 20(1):40-9. PubMed ID: 17244121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.
    Takami Y; Horio T; Iwashima Y; Takiuchi S; Kamide K; Yoshihara F; Nakamura S; Nakahama H; Inenaga T; Kangawa K; Kawano Y
    Am J Kidney Dis; 2004 Sep; 44(3):420-8. PubMed ID: 15332214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients.
    Zeng C; Wei T; Jin L; Wang L
    Intern Med J; 2006 Sep; 36(9):552-7. PubMed ID: 16911545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
    Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
    Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy.
    Demachi J; Kagaya Y; Watanabe J; Sakuma M; Ikeda J; Kakuta Y; Motoyoshi I; Kohnosu T; Sakuma H; Shimazaki S; Sakai H; Kimpara T; Takahashi T; Omura K; Okada M; Saito H; Shirato K
    Neuromuscul Disord; 2004 Nov; 14(11):732-9. PubMed ID: 15482958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease.
    Austin WJ; Bhalla V; Hernandez-Arce I; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL
    Am J Clin Pathol; 2006 Oct; 126(4):506-12. PubMed ID: 16938661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Mabuchi N; Hayashi M; Ohnishi M; Sawaki M; Fujii M; Horie H; Sugimoto Y; Kinoshita M
    Eur Heart J; 1999 Dec; 20(24):1799-807. PubMed ID: 10581138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain natriuretic peptide (BNP) in coronary insufficiency: relationship with left ventricular filling and exercise tolerance].
    Logeart D; Gambert A; Beyne P; Guiti C; Geyer C; Bourgoin P; Alonso C; Ennezat PV; Gourgon R; Cohen-Solal A
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):523-8. PubMed ID: 12555377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.
    Parekh N; Maisel AS
    Curr Opin Cardiol; 2009 Mar; 24(2):155-60. PubMed ID: 19532102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide and acute coronary syndrome.
    Mazzone M; Forte P; Portale G; Mancini F; Ursella S; La Sala M; Testa A; Covino M; Pignataro G; Gentiloni Silveri N
    Minerva Med; 2005 Feb; 96(1):11-8. PubMed ID: 15827538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release pattern of cardiac biomarkers in left ventricular apical ballooning.
    Nef HM; Möllmann H; Weber M; Deetjen A; Brandt R; Hamm CW; Elsässer A
    Int J Cardiol; 2007 Jan; 115(1):128-9. PubMed ID: 16769138
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.
    Palmer SC; Yandle TG; Frampton CM; Troughton RW; Nicholls MG; Richards AM
    Eur Heart J; 2009 Jun; 30(12):1486-94. PubMed ID: 19389787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of B-type natriuretic peptide to assess volume status in dialysis patients.
    Codognotto M; Piccoli A
    Am Heart J; 2007 Nov; 154(5):e31. PubMed ID: 17967574
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
    Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.